Braidwell LP Biogen Inc. Transaction History

Braidwell LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$275.25 - $318.06 $27.2 Million - $31.4 Million	-98,800 Reduced 44.76%	121,942 $34.7 Billion
Q1 2023 May 15, 2023	SELL	$256.56 - $292.34 $8.16 Million - $9.3 Million	-31,800 Reduced 12.59%	220,742 $61.4 Billion
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $63.8 Million - $77.5 Million	252,542 New	252,542 $69.9 Billion

1,006

129M

1.12M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Braidwell LP, based on Form 13F filings with the SEC.

Stay updated on Braidwell LP with notifications on news.